6 reports of this reaction
3.3% of all ACETAMINOPHEN, PHENYLEPHRINE HCL reports
#3 most reported adverse reaction
PNEUMONIA is the #3 most commonly reported adverse reaction for ACETAMINOPHEN, PHENYLEPHRINE HCL, manufactured by Better Living Brands, LLC. There are 6 FDA adverse event reports linking ACETAMINOPHEN, PHENYLEPHRINE HCL to PNEUMONIA. This represents approximately 3.3% of all 184 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, PHENYLEPHRINE HCL who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is moderately reported among ACETAMINOPHEN, PHENYLEPHRINE HCL users, representing a notable but not dominant share of adverse events.
In addition to pneumonia, the following adverse reactions have been reported for ACETAMINOPHEN, PHENYLEPHRINE HCL:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 6 FDA reports for ACETAMINOPHEN, PHENYLEPHRINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 3.3% of all adverse event reports for ACETAMINOPHEN, PHENYLEPHRINE HCL, making it one of the most commonly reported side effect.
If you experience pneumonia while taking ACETAMINOPHEN, PHENYLEPHRINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.